7 related articles for article (PubMed ID: 38741503)
1. Neurological autoimmunity in melanoma patients: a comparison between those exposed and non-exposed to immune checkpoint inhibitors.
Vilaseca A; Farina A; Villagrán-García M; Pegat A; Benaiteau M; Ciano-Petersen NL; Do LD; Rogemond V; Gonçalves D; Psimaras D; Birzu C; Honnorat J; Joubert B
J Neurol; 2024 Jun; 271(6):3279-3290. PubMed ID: 38467790
[TBL] [Abstract][Full Text] [Related]
2. Immune Checkpoint Inhibitors in Patients with Pre-existing Neurologic Autoimmune Disorders.
Aoun R; Gratch D; Kaminetzky D; Kister I
Curr Neurol Neurosci Rep; 2023 Nov; 23(11):735-750. PubMed ID: 37870664
[TBL] [Abstract][Full Text] [Related]
3. Central nervous system adverse events of immune checkpoint inhibitors.
Farina A; Villagrán-García M; Vogrig A; Joubert B
Curr Opin Neurol; 2024 Jun; 37(3):345-352. PubMed ID: 38483130
[TBL] [Abstract][Full Text] [Related]
4. [Peripheral Neuropathy and Muscle Disorders as Immune-Related Adverse Events].
Suzuki S
Brain Nerve; 2024 May; 76(5):605-611. PubMed ID: 38741503
[TBL] [Abstract][Full Text] [Related]
5.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
6.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
7.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
